Trial Profile
A Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Intravenous Lacosamide as Replacement for Oral Lacosamide in Japanese Adults With Partial-onset Seizures With or Without Secondary Generalization
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Lacosamide
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors UCB Japan
- 10 Dec 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 22 Jul 2014 New trial record